DIN 00613231 — TEVA-SPIRONOLACTONE/HCTZ 25 MG; 25 MG
TEVA-SPIRONOLACTONE/HCTZ is a tablet of Hydrochlorothiazide / Spironolactone marketed by TEVA CANADA LIMITED. The full Hydrochlorothiazide / Spironolactone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00613231
- Brand name
- TEVA-SPIRONOLACTONE/HCTZ
- Active ingredient
- Hydrochlorothiazide / Spironolactone
- Strength
- 25 MG; 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Aldosterone antagonist plus thiazide diuretic (fixed-dose combination diuretic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hydrochlorothiazide / Spironolactone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00657182 | TEVA-SPIRONOLACTONE/HCTZ | 50 MG; 50 MG | TABLET | TEVA CANADA LIMITED | MARKETED |